Sanofi lifts 2026 sales outlook to about 10% growth at constant currencies

Reuters2026/07/30 05:35

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sanofi raised its 2026 outlook, targeting revenue growth of about 10% at constant exchange rates.
It expects business EPS growth at constant exchange rates to run slightly above sales growth.
The upgrade follows Q2 revenue of EUR 11.6 billion, up 17.8% at constant exchange rates.
Q2 business EPS was EUR 2.09, up 33.3% at constant exchange rates.
July 2026 FX assumptions imply about a 1% revenue headwind, about a 2% headwind to business EPS.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607300130OMX_____CNEWS_FR_GNW1001255118_fr) on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sanofi lifts 2026 sales outlook to about 10% growth at constant currencies

You may also like

Crypto prices